Mariam Allbee-Johnson
Overview
Explore the profile of Mariam Allbee-Johnson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
33
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hickey C, Zhang M, Allbee-Johnson M, Romee R, Majhail N, Al Malki M, et al.
Transplant Cell Ther
. 2025 Jan;
31(3):174.e1-174.e12.
PMID: 39755256
Background: Post-transplant cyclophosphamide (PTCy) is a commonly used graft-vs-host disease (GVHD) prophylaxis, particularly in the setting of haploidentical (haplo) hematopoietic cell transplantation (HCT). The rate of graft failure has been...
2.
Mercadal S, Ahn K, Allbee-Johnson M, Ganguly S, Ramakrishnan Geethakumari P, Hong S, et al.
Haematologica
. 2024 Sep;
110(1):218-221.
PMID: 39234871
No abstract available.
3.
Turcotte L, Wang T, Beyer K, Cole S, Spellman S, Allbee-Johnson M, et al.
Proc Natl Acad Sci U S A
. 2024 Jul;
121(30):e2404108121.
PMID: 39008669
Low socioeconomic status (SES) is a risk factor for mortality and immune dysfunction across a wide range of diseases, including cancer. However, cancer is distinct in the use of allogeneic...
4.
Cusatis R, Litovich C, Feng Z, Allbee-Johnson M, Kapfhammer M, Mattila D, et al.
Transplant Cell Ther
. 2024 Jun;
30(9):917.e1-917.e12.
PMID: 38944153
The Center for International Blood and Marrow Transplant Research (CIBMTR) prepares an annual set of summary slides to summarize the trends in transplantation and cellular therapies. For the first time...
5.
Bolon Y, Atshan R, Allbee-Johnson M, Estrada-Merly N, Auletta J, Broglie L, et al.
Transplant Cell Ther
. 2024 Jun;
30(9):921.e1-921.e22.
PMID: 38871054
Hematopoietic cell transplantation (HCT) has undergone many advances over the decades. Trends in HCT utilization have been impacted by research based on the data and samples collected by the Center...
6.
Epperla N, Hashmi H, Ahn K, Allbee-Johnson M, Chen A, Wirk B, et al.
Br J Haematol
. 2024 May;
205(3):1202-1207.
PMID: 38797526
No abstract available.
7.
Patel S, Ahn K, Khanal M, Bupp C, Allbee-Johnson M, Majhail N, et al.
Transplant Cell Ther
. 2022 Mar;
28(6):310-320.
PMID: 35314376
Noninfectious pulmonary toxicity (NPT), a significant complication of allogeneic hematopoietic cell transplantation (alloHCT), includes idiopathic pneumonia syndrome (IPS), diffuse alveolar hemorrhage (DAH), and cryptogenic organizing pneumonia (COP), with an overall...
8.
Abou-Ismail M, Fraser R, Allbee-Johnson M, Metheny 3rd L, Ravi G, Ahn K, et al.
Br J Haematol
. 2022 Mar;
197(3):326-338.
PMID: 35286719
It is not known whether obesity has a differential effect on allogeneic haematopoietic cell transplantation outcomes with alternative donor types. We report the results of a retrospective registry study examining...
9.
ODonnell P, Brunstein C, Fuchs E, Zhang M, Allbee-Johnson M, Antin J, et al.
Transplant Cell Ther
. 2021 Nov;
28(2):109.e1-109.e8.
PMID: 34775146
Randomized clinical trials offer the highest-quality data for modifying clinical practice. Results of a phase III randomized trial of nonmyeloablative transplantation for adults with high-risk hematologic malignancies with 2 umbilical...
10.
Orfali N, Zhang M, Allbee-Johnson M, Boelens J, Artz A, Brunstein C, et al.
Transplant Cell Ther
. 2021 Sep;
27(12):993.e1-993.e8.
PMID: 34507002
The in vivo depletion of recipient and donor T lymphocytes using antithymocyte globulin (ATG; Thymoglobulin) is widely adopted in allogeneic hematopoietic stem cell transplantation (HCT) to reduce the incidence of...